CKAP5 and Miyoshi myopathy: To test whether the therapeutic potential of αCD38‐tLNPs can be translated to MM‐bearing mice in vivo, αCD38‐tLNPs encapsulating siRNA‐CKAP5 or siRNA‐NC were injected 7‐, 11‐, 14‐, 17‐ and 21 d post tumor inoculation (Figure6A).